B

Boundless Bio
D

BOLD

1.26000
USD
-0.02
(-1.56%)
مغلق
حجم التداول
200
الربح لكل سهم
-3
العائد الربحي
-
P/E
-1
حجم السوق
28,205,870
المقالات

العنوان: Boundless Bio

القطاع: Healthcare
الصناعة: Biotechnology
Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.